United States

Emerging markets are making up shortfalls that have resulted from a fall in investment from developed countries

We believe the economy is recovering, albeit at a pace that is below trend relative to prior recoveries.

I have just come back from the US having visited Vanguard fund management's campus outside Philadelphia.

Charles Stanley's Stephen Peters considers the pros and cons of selecting two very different investment styles and their potential performance

With deference to Bill Gross, the ‘must-avoids' are, surely, the easy bit. It's my ‘must-haves' that are in short supply.

Looking back over the past decade, the performance of emerging markets has brought approving comments from even the most hardened critics.

Anyone remotely optimistic about prospects for global equities over the next 15 years simply cannot avoid, or significantly underweight, US equities.

Concentrating on US healthcare reform has led many analysts to overlook other positives in the biotechnology sector

The big issues that long term investors must address when looking for investments

North American fund managers argue that US corporates offer the opportunity to benefit from rapidly growing emerging markets and thereby offer the best of both investment worlds